Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from InhaleRx Limited ( (AU:IRX) ).
InhaleRx Limited has requested a trading halt on its securities pending an announcement related to a new drug development program and associated capital raising. This move is intended to manage the company’s continuous disclosure obligations and is expected to conclude with an announcement before the commencement of normal trading on 26 November 2025.
More about InhaleRx Limited
InhaleRx Limited operates in the pharmaceutical industry, focusing on drug development programs. The company is involved in creating complementary assets and is engaged in capital raising activities to support its initiatives.
Average Trading Volume: 257,297
Technical Sentiment Signal: Hold
Current Market Cap: A$7.85M
See more data about IRX stock on TipRanks’ Stock Analysis page.